ANL 36.00 Decreased By ▼ -0.55 (-1.5%)
ASC 14.70 Decreased By ▼ -0.10 (-0.68%)
ASL 25.70 Decreased By ▼ -0.40 (-1.53%)
AVN 89.50 Decreased By ▼ -1.40 (-1.54%)
BOP 7.74 Decreased By ▼ -0.06 (-0.77%)
BYCO 10.08 Decreased By ▼ -0.13 (-1.27%)
DGKC 123.80 Decreased By ▼ -1.40 (-1.12%)
EPCL 58.15 Increased By ▲ 0.65 (1.13%)
FCCL 24.05 Decreased By ▼ -0.30 (-1.23%)
FFBL 29.15 Increased By ▲ 0.35 (1.22%)
FFL 15.75 Decreased By ▼ -0.30 (-1.87%)
HASCOL 9.65 Decreased By ▼ -0.14 (-1.43%)
HUBC 78.75 Decreased By ▼ -0.25 (-0.32%)
HUMNL 6.44 Decreased By ▼ -0.33 (-4.87%)
JSCL 21.20 Decreased By ▼ -0.61 (-2.8%)
KAPCO 39.90 Decreased By ▼ -0.20 (-0.5%)
KEL 3.78 Decreased By ▼ -0.05 (-1.31%)
LOTCHEM 16.68 Increased By ▲ 0.07 (0.42%)
MLCF 46.31 Decreased By ▼ -0.84 (-1.78%)
PAEL 35.65 Increased By ▲ 0.42 (1.19%)
PIBTL 10.22 Decreased By ▼ -0.13 (-1.26%)
POWER 9.19 Decreased By ▼ -0.06 (-0.65%)
PPL 86.23 Increased By ▲ 0.21 (0.24%)
PRL 24.90 Decreased By ▼ -0.42 (-1.66%)
PTC 9.91 Decreased By ▼ -0.10 (-1%)
SILK 1.24 No Change ▼ 0.00 (0%)
SNGP 42.00 Decreased By ▼ -0.05 (-0.12%)
TRG 163.30 Decreased By ▼ -1.45 (-0.88%)
UNITY 30.38 Decreased By ▼ -0.38 (-1.24%)
WTL 1.54 Increased By ▲ 0.06 (4.05%)
BR100 4,862 Decreased By ▼ -11.22 (-0.23%)
BR30 25,689 Decreased By ▼ -158.39 (-0.61%)
KSE100 45,230 Decreased By ▼ -81.04 (-0.18%)
KSE30 18,510 Decreased By ▼ -34.78 (-0.19%)

Coronavirus
VERY HIGH
Pakistan Deaths
15,872
11824hr
Pakistan Cases
739,818
539524hr
Sindh
270,310
Punjab
258,441
Balochistan
20,580
Islamabad
68,066
KPK
102,290

Pfizer vaccine

EU's von der Leyen says EU to receive 50mn more Pfizer shots in Q2

EU's von der Leyen says EU to receive 50mn more Pfizer shots in Q2

  • Ursula von der Leyen said the earlier deliveries, which will start this month, will take total supplies to the EU from Pfizer to 250 million doses in the second quarter of this year.
  • She also confirmed the Commission was in talks with the two companies for a new contract for 1.8 billion doses to be delivered in 2022 and 2023, confirming a Reuters report last week.
Published 14 Apr, 2021 05:32pm
EU seeks new contract with Pfizer for up to 1.8bn vaccines from 2022
Business & Finance

EU seeks new contract with Pfizer for up to 1.8bn vaccines from 2022

  • Earlier on Friday, German daily Die Welt reported that the Commission was shortly to sign contracts to buy up to 1.8 billion doses, but did not say with which company.
  • Pfizer-BioNTech and Moderna are already supplying the EU with mRNA vaccines and German biotech firm CureVac is seeking EU approval for its mRNA shot.
Published 09 Apr, 2021 08:43pm
EU preparing orders for 1.8bn vaccine booster shots
Business & Finance

EU preparing orders for 1.8bn vaccine booster shots

  • The planned orders will be for so-called mRNA vaccines, with a preference for manufacturers who are EU-based or who have production facilities in Europe.
  • Only the Biontech/Pfizer vaccine, which is manufactured in Belgium and Germany, and Moderna, which manufactures in Spain and Switzerland, currently meet these requirements.
Published 09 Apr, 2021 06:54pm
South Africa signs deal for 20mn Pfizer COVID-19 doses
Business & Finance

South Africa signs deal for 20mn Pfizer COVID-19 doses

  • The deal is another fillip for the country worst hit by COVID-19 infections in Africa as it adds to the 31 million single-shot doses from Johnson & Johnson which the government approved on Thursday.
  • The country has also been allocated 12 million shots under the World Health Organization's COVAX scheme and is likely to get doses for 10 million people from the African Union's AVATT initiative.
Updated 06 Apr, 2021 07:29pm
Pfizer says working on new COVID-19 vaccine supply deal to Israel
Business & Finance

Pfizer says working on new COVID-19 vaccine supply deal to Israel

  • Pfizer and its partner BioNTech agreed in November to supply Israel with an undisclosed number of COVID-19 vaccines and Israel's Finance Ministry has said it paid some 2.6 billion shekels ($785 million).
  • Israel's government is seeking to secure 36 million more Pfizer/BioNTech doses for use as booster shots or for children once they are eligible, but that hit a snag last week over political infighting.
Published 05 Apr, 2021 09:23pm
Turkey begins administering Pfizer/BioNTech COVID-19 shots
World

Turkey begins administering Pfizer/BioNTech COVID-19 shots

  • Turkey has so far delivered 16.5 million vaccine doses nationwide, including more than 7 million people who have received a second dose of the shots developed by China's Sinovac Biotech.
  • A total of 2.8 million doses of the Pfizer vaccine have arrived in Turkey, with that number expected to reach 4.5 million in the coming days, Health Minister Fahrettin Koca said on Wednesday.
Published 02 Apr, 2021 06:21pm
Vietnam asks for foreign support in procuring COVID-19 vaccines
World

Vietnam asks for foreign support in procuring COVID-19 vaccines

  • Vietnam has received about 930,000 doses of AstraZeneca's vaccine so far but wants to procure doses from Pfizer , Johnson & Johnson, Moderna, China's Sinovac, and Russia's Sputnik V shot.
  • Health Minister Nguyen Thanh Long on Thursday asked Japan's embassy for help with technology transfer for vaccine production and testing in Vietnam, the ministry said in a statement on Friday
Published 02 Apr, 2021 06:14pm
Pfizer COVID-19 shot 91pc effective in updated data, protective against South African variant
World

Pfizer COVID-19 shot 91pc effective in updated data, protective against South African variant

  • The shot was also 100% effective in preventing illness among trial participants in South Africa, where a new variant called B1351 is dominant, though the number of those participants was relatively small at 800.
  • While the new overall efficacy rate of 91.3% is lower than the 95% originally reported in November for its 44,000-person trial, a number of variants have become more prevalent around the world since then.
Published 01 Apr, 2021 06:23pm
EU drugs regulator gives green light to J&J's single-shot COVID-19 vaccine
Business & Finance

EU drugs regulator gives green light to J&J's single-shot COVID-19 vaccine

  • The COVID-19 shot is the fourth to be endorsed for use in the EU after vaccines from Pfizer-BioNTech , AstraZeneca-Oxford University and Moderna, and is recommended for those over 18 years of age.
  • With this latest positive opinion, authorities across the European Union will have another option to combat the pandemic and protect the lives and health of their citizens.
Published 11 Mar, 2021 06:48pm
Canada approves J&J's one-dose COVID-19 vaccine
Business & Finance

Canada approves J&J's one-dose COVID-19 vaccine

  • The official announcement will be made later on Friday, said the source, who requested anonymity given the sensitivity of the situation.
  • If the J&J vaccine has been approved, it could ease some logistical challenges. The vaccine is administered in a single dose and can be stored in normal fridges while the Pfizer-BioNTech and Moderna shots must be kept in freezers.
Published 05 Mar, 2021 08:28pm
Merck to help make Johnson & Johnson's COVID-19 vaccine
Business & Finance

Merck to help make Johnson & Johnson's COVID-19 vaccine

  • After scrapping development of its own COVID-19 vaccine candidates in January, Merck last month said it was working on a deal to open up its manufacturing capacity to other vaccine makers.
  • J&J is shipping about four million doses of its vaccine in the United States this week, but the next shipments hinge on when its new, larger manufacturing plant receives regulatory approvals.
Published 02 Mar, 2021 08:34pm
'Real-world' UK data shows 70pc decline in COVID infections after first Pfizer shot
World

'Real-world' UK data shows 70pc decline in COVID infections after first Pfizer shot

  • "Overall, we're seeing a really strong effect to reducing any infection, asymptomatic and symptomatic," PHE's strategic response director Susan Hopkins told a media briefing.
  • "Hospitalisation and deaths rates are falling in all age groups, but the oldest age groups are seeing the fastest decline since the peak in mid-January," a PHE statement said.
Published 22 Feb, 2021 09:27pm
Pfizer seeks US approval to ease handling of COVID-19 vaccine
Business & Finance

Pfizer seeks US approval to ease handling of COVID-19 vaccine

  • Pfizer/BioNTech's vaccine, along with Moderna Inc's two-dose shot, won the US emergency use authorization (EUA) and is being widely distributed as part of the country's mass vaccination efforts.
  • The data submitted may facilitate the handling of our vaccine in pharmacies and provide vaccination centers an even greater flexibility.
Published 19 Feb, 2021 07:23pm